Ayumu et al demonstrated that increasing concentration of plasma pro-SFTPB was associated with higher lung cancer risk, which confirmed that SFTPB might be a valuable biomarker in lung cancer risk prediction models [20, 23]. Here, SFTPB is linked to lung cancer.